Highest-materiality recent filing
Babeau will serve as Strategic Advisor through March 31, 2027, receiving base salary of CHF 1,260,012 and eligible for 2026 bonus.
PM finalizes CFO Andolina's compensation: CHF 1.05M base, 125% IC, 275% equity target
Massimo Andolina appointed Group CFO effective Aug 1, 2026, replacing Emmanuel Babeau.
PMI updates FY2026 EPS forecast to $7.18-$7.33; non-cash RBH impairment of ~$500M
Adjusted diluted EPS forecast $8.31-$8.46 (+10.2%-12.2% vs 2025); currency-adjusted growth 7.5%-9.5%.
Philip Morris appoints Massimo Andolina as Group CFO, effective August 1, 2026
Massimo Andolina promoted from President Europe Region to Group CFO, effective August 1, 2026, replacing Emmanuel Babeau.
PMI Q1 adj EPS +16% to $1.96; IQOS becomes #1; updates FY adj EPS forecast for currency
Reported diluted EPS $1.56 (down 9.3% YoY); adjusted diluted EPS $1.96 (up 16.0%, 5.3% excluding currency).
PMI reaffirms 2026 adjusted EPS forecast of $8.38-$8.53, 11.1-13.1% growth
Reaffirmed 2026 reported diluted EPS $7.87-$8.02; adjusted diluted EPS $8.38-$8.53.
PMI FY2025 adjusted EPS $7.54, +14.8%; smoke-free revenues surge; 2026-2028 targets set
Full-year adjusted diluted EPS of $7.54 grew 14.8% YoY, 14.2% currency-neutral.
PMI to Reorganize into PMI International & U.S. Units; de Wilde Named CEO International
Effective Jan 1, 2026: PMI creates PMI International & U.S. business units; Jacek Olczak remains Group CEO.
PMI issues $3.5B in senior notes across five tranches; proceeds to refinance near-term debt
Issued $300M floating rate notes due 2028, $750M 3.875% due 2028, $750M 4.000% due 2030, $850M 4.250% due 2032, $850M 4.625% due 2035.
PMI Q3 adj. EPS $2.24 (+17.3% YoY); raises FY guidance; smoke-free rev +17.7%
Q3 reported diluted EPS $2.23 (+13.2% YoY); adjusted diluted EPS $2.24 (+17.3% YoY; +13.1% excl. currency).
PMI reaffirms FY2025 adj. EPS growth 13-15%; Q3 ZYN offtake accelerates ~32%
Reaffirmed FY2025 reported EPS $7.24-$7.37, adj. EPS $7.43-$7.56 (growth 13-15%).
PMI Q2 adj. EPS $1.91 (+20%), record revenue, raises FY guidance
Reported diluted EPS $1.95 (+26.6% YoY); adjusted diluted EPS $1.91 (+20.1%, ex-currency +18.9%).
PM Q1 2025: reported EPS $1.72 (+24.6%), adjusted EPS $1.69 (+12.7%); raises FY outlook
Reported diluted EPS $1.72 (+24.6%); adjusted diluted EPS $1.69 (+12.7%, or +17.3% excl. currency).
Aggregate settlement CAD 32.5B (~USD 22.7B) funded by upfront cash and annual payments based on a % of net after-tax income.
PMI: FY2024 adj. diluted EPS $6.57 (+9.3%); reported EPS $4.52; smoke-free 40% of net revenue
FY2024 reported diluted EPS $4.52; adjusted diluted EPS $6.57 (+9.3%, +15.6% currency-neutral); $6.01 before Canada impairment $1.49.
FDA authorizes all ZYN nicotine pouches, first authorized nicotine pouch in US
FDA granted marketing authorization for all 20 ZYN nicotine pouch variants (3 mg and 6 mg) marketed by Swedish Match.
Philip Morris International issues $3B in senior notes across four tranches
Issued $750M each of 4.375% notes due 2027, 4.625% due 2029, 4.750% due 2031, and 4.900% due 2034.
Q3 2024 reported diluted EPS $1.97, up 49.2% YoY; adjusted diluted EPS $1.91, up 14.4% (or 18.0% ex-currency).
PMI's Canadian affiliate RBH included in proposed CAD 32.5B settlement of tobacco claims in Canada
RBH, ITL, JTIM would pay aggregate CAD 32.5B (~USD 23.5B) to settle tobacco claims; allocation among companies unresolved.
PMI agrees to sell Vectura Group to Molex for up to GBP 298M; expects ~$220M Q3 loss
Upfront cash consideration of GBP 150M (~$198M) plus up to GBP 148M in contingent milestone payments through 2039.
Philip Morris International raises quarterly dividend 3.8% to $1.35 per share
New quarterly dividend of $1.35 per share, up from $1.30; annualized rate $5.40.
the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company”) approved the appointment of Massimo Andolina, the Company’s current President, Europe Region, to the position of Group Chief Financial Officer, replacing Emmanuel Babeau, effective August 1, 2026.
replacing Emmanuel Babeau, effective August 1, 2026.
On May 18, 2026, the Board of Directors of Philip Morris International Inc. (the “Company”) approved the appointment of Massimo Andolina, the Company’s current President, Europe Region, as Group Chief Financial Officer, replacing Emmanuel Babeau, effective August 1, 2026.
Mr. Babeau will remain with the Company as Strategic Advisor to Jacek Olczak, Group CEO PMI through March 31, 2027 and to assist Mr. Andolina with his transition.
On September 13, 2023, Ms. Victoria Harker (age 59) was appointed to serve on the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company”), effective January 1, 2024.
Drago Azinovic, currently President, Middle East and Africa and PMI Duty Free Region, will leave the organization after a transition period in connection with the Company’s new regional structure and related senior management changes.
On January 5, 2023, Frederik Paulsen informed the Executive Chairman of the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company” or "PMI") that he will not stand for re-election to the Board at the Company’s 2023 Annual Meeting of Shareholders (the “2023 Annual Meeting”).
On January 10, 2023, Lucio A. Noto informed the Executive Chairman of the Board and the Company's Chief Executive Officer that he will also not stand for re-election to the Board at the Company’s 2023 Annual Meeting.
Frederic de Wilde, currently President, European Union Region, will be appointed President, South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS), Middle East and Africa (MEA) Region.
On December 8, 2022, the Board of Directors (the “Board”) of Philip Morris International Inc. (the “Company”) approved the appointment of Jorge Insuasty as the full-time President, Vectura Fertin Pharma, effective January 1, 2023.
Drago Azinovic, currently President, Middle East and Africa and PMI Duty Free Region, will leave the organization after a transition period.
Ms. Dessislava Temperley (age 48) was appointed to the Board of Directors (the "Board") of Philip Morris International Inc. (the "Company") effective December 6, 2021.
Max materiality 0.90 · Median 0.55 · Most common event debt